Skip to main content
. 2015 May 11;33(19):2212–2220. doi: 10.1200/JCO.2015.61.3745

Fig 2.

Fig 2.

Risk-adaptive hepatitis B virus (HBV) screening and management decision-making algorithm for patients with cancer before immunosuppressive therapy. anti-HBc, antihepatitis B core antibody (either total or immunoglobulin G); HBsAg, hepatitis B surface antigen.